Philip Rowe
- Pharmaceutical Science top 0.5%
- Geriatrics and Gerontology top 1%
- Computational Theory and Mathematics top 2%
- Toxicology top 1%
- Molecular Biology
- Co-authors
- James L. FordDavid R. MottramChristopher F. GreenMunir PirmohamedMatthew RobertsMaría V. VelascoAli R. Rajabi‐SiahboomiM Cronin
- Topics
- Pharmaceutical Practices and Patient Outcomes (11 papers)Drug Solubulity and Delivery Systems (7 papers)Computational Drug Discovery Methods (7 papers)
- Partner nations
- United KingdomUnited StatesBulgaria
In The Last Decade
Philip Rowe
37 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 138
- Pharmaceutical Science 532
- Geriatrics and Gerontology 259
- Computational Theory and Mathematics 240
- Toxicology 195
- Molecular Biology 189
Countries citing papers authored by Philip Rowe
This map shows the geographic impact of Philip Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Rowe more than expected).
Fields of papers citing papers by Philip Rowe
This network shows the impact of papers produced by Philip Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Rowe. The network helps show where Philip Rowe may publish in the future.
Co-authorship network of co-authors of Philip Rowe
This figure shows the co-authorship network connecting the top 25 collaborators of Philip Rowe. A scholar is included among the top collaborators of Philip Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Rowe. Philip Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 8 | |
| 3 | 27 | |
| 4 | 25 | |
| 5 | 13 | |
| 6 | 7 | |
| 7 | 53 | |
| 8 | 4 | |
| 9 | 22 | |
| 10 | 87 | |
| 11 | 54 | |
| 12 | 127 | |
| 13 | 74 | |
| 14 | 150 | |
| 15 | 184 | |
| 16 | 9 | |
| 17 | 35 | |
| 18 | 47 | |
| 19 | 29 | |
| 20 | 133 |
About Philip Rowe
Philip Rowe is a scholar working on Geriatrics and Gerontology, Toxicology and Pharmaceutical Science, having authored 37 papers that have together received 1.5k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (11 papers), Drug Solubulity and Delivery Systems (7 papers) and Computational Drug Discovery Methods (7 papers). The work is most often cited by research in Pharmaceutical Science (532 citations), Geriatrics and Gerontology (259 citations) and Toxicology (195 citations). Philip Rowe has collaborated with scholars based in United Kingdom, United States and Bulgaria. Frequent co-authors include James L. Ford, David R. Mottram, Christopher F. Green, Munir Pirmohamed, Matthew Roberts, María V. Velasco, Ali R. Rajabi‐Siahboomi, M Cronin, Judith C. Madden and Michael Rubinstein. Their work appears in journals such as Chemosphere, Journal of Controlled Release and Computers & Education.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.